Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical, chemical, and microscopic tests. It involves checking the appearance, concentration and content of urine. Presence of specific substances in the urine can signify the presence of a disease. Urinalysis test constitutes of two types of tests, viz. sediment urinalysis and biochemical urinalysis.
The global urinalysis market is mainly driven by rising prevalence of kidney diseases & urinary tract infections (UTIs), growing adoption of point-of-care (PoC) urinalysis testing and favorable government policies. Launch of automated, standardized, scalable, and integrated urinalysis solutions is also playing a pivotal role in contributing to the growth of the market globally. However, dearth of skilled laboratory professionals and limitations of urine dipstick testing are likely to restrain the market growth to a certain extent.
The global urinalysis market has been analyzed from five perspectives: Test Type, Product Type, Application, End User and Region.
Based on test type, the urinalysis market has been segmented into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis segment holds the largest share in the market owing to continuous technological advancements and its widespread adoption.
Based on product type, the urinalysis market has been segmented into consumables and instruments. The consumables segment holds the largest share in the market. Consumables consists of kits, reagents and other components of urinalysis. The growth of the segment can be attributed to its easy accessibility and its frequent purchase for each test performed as compared to the one-time purchase of instruments.
Based on application, the market has been segmented into pregnancy tests and disease diagnostics. The disease diagnostics segment accounted for the largest share in the market. Urinalysis is a reliable technique for the diagnosis of various urological conditions, namely urinary tract infection (UTI), calculi and malignancy, among others. Urinalysis tests can be performed among cases of hematuria, as routine check-up for both children & adults, for individuals with symptoms of urinary tract infection (UTI) and candidates with high risks of renal diseases.
Based on end user, the urinalysis market has been segmented into hospitals, diagnostics centers and others (research & academic institutes, home care settings, etc.). The hospitals segment holds the largest share in the market. Urinalysis is the most common diagnostic and lab screening test performed in hospitals globally, thereby contributing to the growth of the segment.
Based on region, the global urinalysis market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the urinalysis market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to its well-developed healthcare facilities, increasing adoption of highly advanced urinalysis analyzers in hospital settings, increasing incidence of chronic kidney diseases & urinary tract infections and presence of prominent players in the region.
The market is marked by presence of prominent players such as F. Hoffmann-La Roche Ltd, Sysmex, Beckman Coulter, Inc., ARKRAY USA, Inc., Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., URIT Medical Electronic Co., Ltd., 77 Elektronika Kft. Other players operating in the market are Cardinal Health, Quidel Corporation, among others
• In Aug 2020, Sysmex America announced an exclusive agreement with Siemens Healthineers that grants Sysmex America North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use
• In Jan 2020, Sysmex Corporation entered into an agreement to invest in Astrego Diagnostics AB. Through this investment, Sysmex aims to help commercialize a rapid drug susceptibility test1 that Astrego is developing for urinary tract infections
• In Jan 2019, Bio-Rad Laboratories, Inc., announced the launch of qUAntify Advance Control for use in clinical labs performing urinalysis testing. The qUAntify Advance Control is an independent quality control used to monitor the precision of laboratory urinalysis test procedures
• Quantitative (market size and forecasts) and qualitative insights of the market across years - historical years, current year and forecasted years
• Deep-rooted insights on headwinds, tailwinds and opportunities prevailing in the market
• Quantitative (market size and forecasts) and qualitative insights at segment and sub-segment level
• Comprehensive quantitative (market size and forecasts) and qualitative insights on geographic, regional and country level markets
• Granular insights on the competitive landscape prevailing in the market
• Competitive mapping of strategic developments
|Market Size Period||2018-2031|
|Market Segments||Asessment of Urinalysis Market By:
• Test Type
• Product Type
|Geographic Scope||• North America
◦ Rest of Europe (RoE)
• Asia Pacific
◦ Rest of Asia Pacific (RoAPAC)
• Rest of the World
◦ Latin America
◦ Middle East & Africa
|Companies Covered||F. Hoffmann-La Roche Ltd, Sysmex, Beckman Coulter, Inc., ARKRAY USA, Inc., Siemens Healthcare GmbH, Abbott, Bio-Rad Laboratories, Inc., ACON Laboratories, Inc., URIT Medical Electronic Co., Ltd., 77 Elektronika Kft, Cardinal Health, Quidel Corporation, among others.|
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
5.4 Technological Advancements
6 GLOBAL URINALYSIS MARKET - ANALYSIS & FORECAST, BY TEST TYPE
6.1 Biochemical Urinalysis
6.2 Sediment Urinalysis
7 GLOBAL URINALYSIS MARKET - ANALYSIS & FORECAST, BY PRODUCT TYPE
8 GLOBAL URINALYSIS MARKET - ANALYSIS & FORECAST, BY APPLICAION
8.1 Pregnancy Tests
8.2 Disease Diagnostics
9 GLOBAL URINALYSIS MARKET - ANALYSIS & FORECAST, BY END USER
9.2 Diagnostics Centers
9.3 Others (Research & Academic Institutes, Home Care Settings, Etc.)
10 GLOBAL URINALYSIS MARKET - ANALYSIS & FORECAST, BY REGION
10.1 North America Urinalysis Market
10.1.1 North America Urinalysis Market, By Country
10.1.2 North America Urinalysis Market, By Test Type
10.1.3 North America Urinalysis Market, By Product Type
10.1.4 North America Urinalysis Market, By Application
10.1.5 North America Urinalysis Market, By End User
10.2 Europe Urinalysis Market
10.2.1 Europe Urinalysis Market, By Country/Region
10.2.1.4 Rest of Europe (ROE)
10.2.2 Europe Urinalysis Market, By Test Type
10.2.3 Europe Urinalysis Market, By Product Type
10.2.4 Europe Urinalysis Market, By Application
10.2.5 Europe Urinalysis Market, By End User
10.3 Asia Pacific Urinalysis Market
10.3.1 Asia Pacific Urinalysis Market, By Country/Region
10.3.1.4 Rest of Asia Pacific (RoAPAC)
10.3.2 Asia Pacific Urinalysis Market, By Test Type
10.3.3 Asia Pacific Urinalysis Market, By Product Type
10.3.4 Asia Pacific Urinalysis Market, By Application
10.3.5 Asia Pacific Urinalysis Market, By End User
10.4 Rest of the World (RoW) Urinalysis Market
10.4.1 Rest of the World Urinalysis Market, By Region
10.4.1.1 Latin America
10.4.1.2 Middle East & Africa
10.4.2 Rest of The World Urinalysis Market, By Test Type
10.4.3 Rest of The World Urinalysis Market, By Product Type
10.4.4 Rest of The World Urinalysis Market, By Application
10.4.5 Rest of The World Urinalysis Market, By End User
11 COMPANY PROFILES
11.1 F. Hoffmann-La Roche Ltd
11.1.1 Business Overview
11.1.2 Financial Metrics*
11.1.3 Product Portfolio
11.1.4 Key Developments
11.3 Beckman Coulter, Inc.
11.4 ARKRAY USA, Inc.
11.5 Siemens Healthcare GmbH
11.7 Bio-Rad Laboratories, Inc.
11.8 ACON Laboratories, Inc.
11.9 URIT Medical Electronic Co., Ltd.
11.10 77 Elektronika Kft
*Insights on financial metrics is subject to availability of information in the public domain
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...